AU2002220697A1 - Isolated luciferases lu164, lual and lu22, and the use of the same - Google Patents

Isolated luciferases lu164, lual and lu22, and the use of the same

Info

Publication number
AU2002220697A1
AU2002220697A1 AU2002220697A AU2069702A AU2002220697A1 AU 2002220697 A1 AU2002220697 A1 AU 2002220697A1 AU 2002220697 A AU2002220697 A AU 2002220697A AU 2069702 A AU2069702 A AU 2069702A AU 2002220697 A1 AU2002220697 A1 AU 2002220697A1
Authority
AU
Australia
Prior art keywords
lual
same
luciferases
isolated
isolated luciferases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002220697A
Inventor
Ludmila Frank
Stefan Golz
Bernd Kalthof
Svetlana Markova
Eugene Vysotski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002220697A1 publication Critical patent/AU2002220697A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y113/00Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12007Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90241Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Abstract

The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
AU2002220697A 2000-11-23 2001-11-12 Isolated luciferases lu164, lual and lu22, and the use of the same Withdrawn AU2002220697A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10058091A DE10058091A1 (en) 2000-11-23 2000-11-23 Isolated Luciferases Lu164, LuAL and Lu22, and their use
DE10058091 2000-11-23
PCT/EP2001/013057 WO2002042469A1 (en) 2000-11-23 2001-11-12 Isolated luciferases lu164, lual and lu22, and the use of the same

Publications (1)

Publication Number Publication Date
AU2002220697A1 true AU2002220697A1 (en) 2002-06-03

Family

ID=7664340

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2002220697A Withdrawn AU2002220697A1 (en) 2000-11-23 2001-11-12 Isolated luciferases lu164, lual and lu22, and the use of the same
AU2487602A Pending AU2487602A (en) 2000-11-23 2001-11-22 Isolated luciferases and the use thereof
AU2002224876A Expired AU2002224876B2 (en) 2000-11-23 2001-11-22 Isolated luciferases and the use thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2487602A Pending AU2487602A (en) 2000-11-23 2001-11-22 Isolated luciferases and the use thereof
AU2002224876A Expired AU2002224876B2 (en) 2000-11-23 2001-11-22 Isolated luciferases and the use thereof

Country Status (19)

Country Link
US (4) US7297483B2 (en)
EP (1) EP1339853B1 (en)
JP (2) JP4179877B2 (en)
KR (1) KR100841808B1 (en)
CN (4) CN1303214C (en)
AT (1) ATE335824T1 (en)
AU (3) AU2002220697A1 (en)
BR (2) BR0115534A (en)
CA (1) CA2429451C (en)
DE (2) DE10058091A1 (en)
DK (1) DK1339853T3 (en)
ES (1) ES2271111T3 (en)
HK (3) HK1061044A1 (en)
IL (2) IL155878A0 (en)
MX (1) MXPA03004539A (en)
PL (1) PL206385B1 (en)
PT (1) PT1339853E (en)
WO (2) WO2002042469A1 (en)
ZA (1) ZA200303928B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10058091A1 (en) * 2000-11-23 2002-06-06 Bayer Ag Isolated Luciferases Lu164, LuAL and Lu22, and their use
DE102007005804A1 (en) * 2007-02-06 2008-08-07 Bayer Healthcare Ag Secreted luciferase Lu164M3 and its use
DE102007005803A1 (en) * 2007-02-06 2008-08-07 Bayer Healthcare Ag Secreted Luciferase MLuc7 and its use
JP5605727B2 (en) 2010-04-06 2014-10-15 Jnc株式会社 Coelenterazine analogs and coelenteramide analogs
JP6147669B2 (en) * 2010-12-03 2017-06-14 ジーン・ストリーム・ピーティワイ・リミテッド Improved light emitting molecule
US8435777B1 (en) 2012-01-20 2013-05-07 Cayla CPG-free gene for a new secreted reporter protein
JP6132350B2 (en) * 2012-10-26 2017-05-24 国立研究開発法人産業技術総合研究所 Artificial bioluminescent enzyme
US10533231B2 (en) 2012-10-26 2020-01-14 National Institute Of Advanced Industrial Science And Technology Artificial bioluminescent enzyme
BR112015013710B1 (en) * 2012-12-12 2022-08-09 Promega Corporation IN VITRO METHODS TO DETECT AN INTERACTION BETWEEN A BIOACTIVE AGENT AND A CELLULAR TARGET
US10214766B2 (en) 2013-10-18 2019-02-26 National Institute Of Advanced Industrial Science And Technology Luminescent substrate for use in artificial bioluminescent enzyme

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604123A (en) * 1988-08-09 1997-02-18 Toray Industries, Inc. Luciferase, gene encoding the same and production process of the same
US5838313A (en) * 1995-11-20 1998-11-17 Siemens Corporate Research, Inc. Multimedia-based reporting system with recording and playback of dynamic annotation
DE69938293T2 (en) * 1998-03-27 2009-03-12 Bruce J. Beverly Hills Bryan LUCIFERASE, GFP FLUORESCENCE PROTEINS, CODING NUCLEIC CAUSE, AND ITS USE IN DIAGNOSIS
US6853375B2 (en) * 2000-05-10 2005-02-08 Cognos Incorporated Method for preemptive screen rendering
DE10058091A1 (en) * 2000-11-23 2002-06-06 Bayer Ag Isolated Luciferases Lu164, LuAL and Lu22, and their use
US6643635B2 (en) * 2001-03-15 2003-11-04 Sagemetrics Corporation Methods for dynamically accessing, processing, and presenting data acquired from disparate data sources
US8036939B2 (en) * 2001-06-08 2011-10-11 Servigistics, Inc. Reporting in a supply chain
US7587755B2 (en) * 2004-07-02 2009-09-08 Citrix Systems, Inc. System and method for executing interactive applications with minimal privileges
US20060230234A1 (en) * 2005-03-30 2006-10-12 Sap Ag. Browser cache management
US7779347B2 (en) * 2005-09-02 2010-08-17 Fourteen40, Inc. Systems and methods for collaboratively annotating electronic documents
US7831464B1 (en) * 2006-04-06 2010-11-09 ClearPoint Metrics, Inc. Method and system for dynamically representing distributed information

Also Published As

Publication number Publication date
DK1339853T3 (en) 2006-11-13
PT1339853E (en) 2006-12-29
BRPI0115534B1 (en) 2017-07-18
US7297483B2 (en) 2007-11-20
HK1154623A1 (en) 2012-04-27
CN102732537A (en) 2012-10-17
CA2429451A1 (en) 2002-05-30
IL155878A (en) 2011-03-31
JP2008054689A (en) 2008-03-13
IL155878A0 (en) 2003-12-23
US20100184185A1 (en) 2010-07-22
JP2004516828A (en) 2004-06-10
WO2002042469A1 (en) 2002-05-30
WO2002042470A1 (en) 2002-05-30
KR100841808B1 (en) 2008-06-26
CN101979586B (en) 2012-08-08
KR20030051865A (en) 2003-06-25
US8236540B2 (en) 2012-08-07
EP1339853B1 (en) 2006-08-09
PL206385B1 (en) 2010-08-31
ES2271111T3 (en) 2007-04-16
JP4179877B2 (en) 2008-11-12
CN101979586A (en) 2011-02-23
DE50110723D1 (en) 2006-09-21
CN1476481A (en) 2004-02-18
US20130115641A1 (en) 2013-05-09
PL362774A1 (en) 2004-11-02
CN1847399A (en) 2006-10-18
EP1339853A1 (en) 2003-09-03
DE10058091A1 (en) 2002-06-06
AU2487602A (en) 2002-06-03
US20040219527A1 (en) 2004-11-04
ZA200303928B (en) 2004-05-21
CN1303214C (en) 2007-03-07
CA2429451C (en) 2010-10-19
CN1847399B (en) 2010-12-15
HK1096423A1 (en) 2007-06-01
HK1061044A1 (en) 2004-09-03
JP4519163B2 (en) 2010-08-04
AU2002224876B2 (en) 2007-04-05
US20150247131A1 (en) 2015-09-03
US9745557B2 (en) 2017-08-29
ATE335824T1 (en) 2006-09-15
MXPA03004539A (en) 2004-03-26
BR0115534A (en) 2003-09-09

Similar Documents

Publication Publication Date Title
HK1154623A1 (en) Isolated luciferases and the use thereof
MXPA02002901A (en) Lysosomal targeting pathway enzymes.
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
MXPA03005960A (en) Novel mixtures of microbial enzymes.
AU2002215935A1 (en) Novel use of short-chained carboxylic acids
AU6589094A (en) 7-deazapurine modified oligonucleotides
EP2169076A3 (en) Enzymes having alpha amylase activity and methods of use thereof
AU2001242299A1 (en) Fungal transcriptional activator useful in methods for producing polypeptides
AU8738401A (en) Novel kallikrein gene
AU3227700A (en) Skin sanitizing compositions
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2002365646A1 (en) Novel proteins with il-6 inhibiting activity
AUPP472398A0 (en) Protease susceptibility II
AU2001269575A1 (en) Nucleic acid sequences and proteins involved in cellular senescence
HK1088016A1 (en) Isolated fluorescent protein from clytia gregaria cgfp and use thereof
AU2003233222A1 (en) Aqueous polyurethane preparations
GB0020331D0 (en) Enzyme
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
AU2002228683A1 (en) Wooden leg gene, promoter and uses thereof
ES2171136A1 (en) Enzyme with proteolytic activity
WO2001068846A3 (en) Transcription activator of the cited family
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
WO2005057486A3 (en) Protein engineering with analogous contact environments
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
MXPA02002864A (en) Self cleaving rna sequences and their use for the control of protein synthesis.